跳至主要内容
临床试验/NCT06404177
NCT06404177招募中3 期

Dexketoprofen ® IV Versus Piroxicam® IM in Emergency Pain Management

Riadh Boukef1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
Time to pain resolution

研究概览

简要总结

For pain of traumatic origin, the RICE protocol (Rest, Ice, Compression, Elevation) is the main therapeutic measure during the first 4 to 5 days post-trauma. However, there is currently insufficient evidence that this protocol is effective [4].

In the emergency department, paracetamol, NSAIDs or a combination of several molecules are generally prescribed. Patients even use these drugs without a prescription.

The aim of this study is to Compare the effect of dexketoprofen® IV versus piroxen® IM in the treatment of pain in emergency departments.

详细描述

This was a prospective, randomized, double-blind, controlled study conducted at the Sahloul emergency department, Sousse.

Study duration: 3 months.

Inclusion criteria:

Patients over 18 years of age requiring analgesia for acute pain of traumatic origin and who signed a written consent form were included in this study.

Exclusion criteria:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years of age who required analgesia for acute pain of traumatic origin and who signed a written consent form were included in the study.

排除标准

  • Patients who meet the following conditions:
  • refusal, incapacity, difficulties with consent or communication
  • Patients with chronic pain.
  • Any known allergy or secondary reaction to piroxen or dexketoprofen trometamol.
  • Pregnant women.
  • Cirrhosis of the liver.

研究组 & 干预措施

Dexketoprofen

Experimental

Patients receive a perfusion of Dexketoprofen in intraveinous with an injection of istonic saline IM injection

干预措施: Dexketoprofen (Drug)

Piroxicam

Active Comparator

Patients receive an intramuscular injection of piroxicam with an intravenous isotonic saline

干预措施: Piroxicam (Drug)

结局指标

主要结局

Time to pain resolution

时间窗: 120 minutes

VAS\<3

次要结局

  • rescue tratment(120 minutes)
  • Side effects(7 days)
  • patient satisfaction(7 days)

研究者

发起方
Riadh Boukef
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Riadh Boukef

professor

Hôpital Universitaire Sahloul

研究点 (1)

Loading locations...

相似试验